Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Candel Therapeutics (NASDAQ:CADL) reported quarterly losses of $(0.74) per share. This is a 124.24 percent decrease over losses of $(0.33) per share from the same period last year.
Posted In: CADL